you are viewing a single comment's thread.
He said many players interested, but BIG Pharma will probably wait. Doesn't mean that a smaller player can't pony up some serious cash...
True a small player could pony up the cash but YM will most likely seek a partner with some marketing power.How about Sanofi who markets taxotere or Pfizer who I believe markets epirubicin. R
The good news is they will have to pay more AFTER a 2nd successful PIII.